(Q40654479)

22 September 2017

title

Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies (English)

1 reference

22 September 2017

0 references

3

Diana Zelenika

1 reference

22 September 2017

Eric Deutsch

4

0 references

Jerzy Klijanienko

6

object named as

Jerzy Klijanienko

1 reference

22 September 2017

Bassam Abdulkarim

1

1 reference

22 September 2017

Siham Sabri

2

1 reference

22 September 2017

Valerie Frascogna

5

1 reference

22 September 2017

William Vainchenker

7

1 reference

22 September 2017

Irène Joab

8

1 reference

22 September 2017

Jean Bourhis

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

15

1 reference

22 September 2017

page(s)

2260-2271

1 reference

Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

A novel selective broad-spectrum anti-DNA virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Epstein-Barr virus: LMP1 masquerades as an active receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

LMP1 structure and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Apoptotic pathways: paper wraps stone blunts scissors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Programmed cell death: apoptosis and oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Induction of Transcription of "Immediate Early Genes" by Low-Dose Ionizing Radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Radiation induction of immediate early genes: effectors of the radiation-stress response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206402

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206402

1 reference

Dimensions Publication ID

22 September 2017

1039182154

0 references

1 reference